G1 Therapeutics, Inc. posts annual revenue of $51.30 million in 2022

G1 Therapeutics, Inc. [GTHX] has reported $147.56 million profit for the fiscal year ending Dec 31, 2022.

Revenue for the year was $51.30 million with operating income of $136.18 million.

The Researchtrianglepark, North Carolina (NC)-based company operating in the pharmaceutical preparations sector with 170 employees has total shareholders equity of $68.75 million.

Also read:

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.